CVS Health Co. (NYSE:CVS) Stock Position Decreased by Fisher Asset Management LLC

Fisher Asset Management LLC lessened its holdings in shares of CVS Health Co. (NYSE:CVS) by 1.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 68,380 shares of the pharmacy operator’s stock after selling 852 shares during the quarter. Fisher Asset Management LLC’s holdings in CVS Health were worth $5,399,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Bryn Mawr Capital Management LLC boosted its stake in CVS Health by 74.0% during the 3rd quarter. Bryn Mawr Capital Management LLC now owns 43,213 shares of the pharmacy operator’s stock valued at $3,017,000 after purchasing an additional 18,385 shares during the period. Sonora Investment Management Group LLC increased its stake in CVS Health by 1.6% during the third quarter. Sonora Investment Management Group LLC now owns 50,488 shares of the pharmacy operator’s stock valued at $3,525,000 after acquiring an additional 774 shares during the period. Checchi Capital Advisers LLC lifted its position in shares of CVS Health by 2.3% in the 3rd quarter. Checchi Capital Advisers LLC now owns 10,405 shares of the pharmacy operator’s stock worth $726,000 after acquiring an additional 233 shares during the period. Personal CFO Solutions LLC grew its holdings in shares of CVS Health by 2.6% during the 3rd quarter. Personal CFO Solutions LLC now owns 19,355 shares of the pharmacy operator’s stock worth $1,351,000 after purchasing an additional 491 shares in the last quarter. Finally, Riverpoint Wealth Management Holdings LLC bought a new stake in shares of CVS Health during the fourth quarter valued at approximately $218,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Down 0.4 %

Shares of CVS opened at $55.74 on Wednesday. The firm has a market capitalization of $69.97 billion, a price-to-earnings ratio of 9.80, a PEG ratio of 0.88 and a beta of 0.56. CVS Health Co. has a 52 week low of $53.70 and a 52 week high of $83.25. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.61 and a current ratio of 0.81. The business’s fifty day moving average price is $71.95 and its two-hundred day moving average price is $73.09.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share for the quarter, missing the consensus estimate of $1.69 by ($0.38). CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The firm had revenue of $88.44 billion for the quarter, compared to the consensus estimate of $89.33 billion. The business’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.20 earnings per share. On average, analysts predict that CVS Health Co. will post 7.03 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.77%. The ex-dividend date was Friday, April 19th. CVS Health’s dividend payout ratio (DPR) is currently 46.75%.

Insider Buying and Selling

In related news, Director Edward J. Ludwig bought 1,000 shares of the business’s stock in a transaction on Thursday, May 2nd. The shares were purchased at an average price of $53.88 per share, with a total value of $53,880.00. Following the completion of the purchase, the director now owns 21,630 shares of the company’s stock, valued at approximately $1,165,424.40. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of CVS Health stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the transaction, the executive vice president now directly owns 39,765 shares in the company, valued at $3,059,916.75. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Edward J. Ludwig purchased 1,000 shares of the stock in a transaction on Thursday, May 2nd. The stock was acquired at an average price of $53.88 per share, with a total value of $53,880.00. Following the completion of the acquisition, the director now directly owns 21,630 shares of the company’s stock, valued at $1,165,424.40. The disclosure for this purchase can be found here. 0.24% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on CVS. Wells Fargo & Company lowered their price target on shares of CVS Health from $76.00 to $60.00 and set an “equal weight” rating on the stock in a report on Tuesday. Bank of America lowered their target price on shares of CVS Health from $95.00 to $77.00 and set a “buy” rating on the stock in a research note on Thursday, May 2nd. The Goldman Sachs Group cut their price target on shares of CVS Health from $85.00 to $74.00 and set a “buy” rating for the company in a research note on Thursday, May 2nd. Truist Financial reiterated a “buy” rating and issued a $66.00 price objective (down from $90.00) on shares of CVS Health in a research note on Thursday, May 2nd. Finally, Cantor Fitzgerald lowered CVS Health from an “overweight” rating to a “neutral” rating and decreased their price target for the company from $87.00 to $58.00 in a research note on Wednesday, May 1st. Nine investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat, CVS Health has an average rating of “Moderate Buy” and an average price target of $77.55.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.